Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$343K Sell
2,724
-5,519
-67% -$702K 0.01% 577
2017
Q1
$1.1M Buy
+8,243
New +$1.05M 0.02% 332
2016
Q1
Sell
-3,958
Closed -$429K 726
2015
Q4
$429K Sell
3,958
-3,475
-47% -$388K 0.01% 438
2015
Q3
$820K Buy
7,433
+450
+6% +$50.5K 0.02% 321
2015
Q2
$728K Buy
6,983
+3,055
+78% +$316K 0.01% 363
2015
Q1
$360K Buy
+3,928
New +$325K 0.01% 477

Other funds holding INCY

Geneva Advisors's INCY Position: Q2 2017 in Review

Geneva Advisors reduced its Incyte (INCY) stake by 67% in Q2 2017, selling an estimated $702K and leaving 2,724 shares worth $343K. The position accounts for 0.01% of the portfolio, ranked #577.

Geneva Advisors first reported a position in INCY in Q1 2015 and has held it in 6 quarters since. The position peaked at $1.1M in Q1 2017. 493 funds tracked by Wall St. Rank hold INCY as of Q2 2017.

  • Geneva Advisors held 2,724 shares of Incyte worth $343K as of Q2 2017.
  • Geneva Advisors sold 5,519 Incyte shares in Q2 2017, an estimated $702K.
  • Incyte made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #577 holding.
  • Geneva Advisors first reported a position in Incyte in Q1 2015 and has held it in 6 quarters since.
  • Geneva Advisors's Incyte position peaked at $1.1M in Q1 2017.
  • 493 funds tracked by Wall St. Rank held Incyte as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.